+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in the Netherlands

  • PDF Icon

    Report

  • 23 Pages
  • September 2024
  • Region: Netherlands
  • Euromonitor International
  • ID: 316726
The market for analgesics in the Netherlands is anticipated to experience positive growth in current value terms in 2024. As consumers return to their busy and often stressful pre-pandemic routines, there is likely to be an increased demand for effective pain management solutions. Dutch consumers are also increasingly willing to invest in more advanced analgesic formats that promise more faster relief while minimising risks associated with self-medication.

The Analgesics in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Return to busy lifestyles impacts demand, while shift towards more advanced formulations, coupled with price increases, drive value growth
  • Expanding range of formats offer consumers greater choice
  • Consumer shift towards affordable private label alternatives
PROSPECTS AND OPPORTUNITIES
  • Promotion of self-care will boost demand for analgesics, as government seeks to curb healthcare spending
  • Product segmentation offers opportunities to counter market maturity
  • Growth potential for lesser known analgesics
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2019-2024
  • Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
  • Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
  • Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN THE NETHERLANDS
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What’s next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventative medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources